Unlocking Precision in Diagnosis: The Rise of Molecular Point-of-Care Solutions

News provided by

Apr 01, 2024, 18:00 ET

DUBLIN, April 1, 2024 /PRNewswire/ -- The "Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition" report has been added to ResearchAndMarkets.com's offering.

Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology.

The Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition, is a valuable resource for understanding the size and growth potential of the molecular POC market from 2023-2028. mPOC has transitioned from a novel trend to a significant contributor to the market. Instruments from companies like Abbott, BioMerieux, Cepheid, and others play a substantial role in the IVD point-of-care market. Understanding these markets is crucial for assessing the opportunity in point-of-care testing and microbiology IVD.

The report provides market sizing, forecasting, trend mapping, and competitive analysis for POC tests using PCR or other molecular technology, offering fast turnaround times and usability in near-patient settings.

This report provides real-world analysis and modeling for relevant circumstances. Analysts offer insights into near-patient molecular testing using small instruments.

The data includes the following information on systems, competitor analysis, and the size and growth of the market:

What are the mPOC market opportunities beyond COVID-19?
What are the current systems on the market? Who's winning?
What's the size of the Molecular Point-of-Care Market: 2023-2028
Geographic Breakout of the Molecular Point-of-Care Market, 2023 (N. America, Europe, APAC, RoW)
Segment Breakout of Molecular Point-of-Care Market, 2023 (Respiratory vs. Other)
Near Patient Molecular IVD Market: 2023-2028
Near Patient Molecular Market Share by Vendor, 2023
Company Profiles

Competitive Analysis

Companies covered in this report, in profiles and/or product tables and market developments discussion include:

Abbott Laboratories
Aidian
Akonni Biosystems
Anitoa
binx health
Biocartis
BioGX
bioMerieux
Cepheid
Credo Bioscience
Cue Health
Curetis
Curiosity Diagnostics (Bio-Rad)
DiaSorin
Domus Diagnostics
Fluxergy
GenMark Diagnostics
Genomadix
Greiner Bio-One
LEX Diagnostics
Meridian Bioscience
Mesa Biotech
MicroGEM
Minute Molecular
Nanopath
QIAGEN
QuantuMDx Group
Quidel
Roche
Rover Diagnostics
Sekisui Diagnostics
T2 Biosystems

Key Topics Covered:

Chapter 1: Executive Summary

Where is Molecular Point-Of-Care in 2024?
Molecular Point-Of-Care Market Analysis
Market Observations
"Near-Patient" Molecular Systems Market
Current Trends
Molecular Point-Of-Care Diagnostics Defined
Usage of Molecular Point-Of-Care
Leading MPOC Platforms
Trends

Chapter 2: Molecular Point-Of-Care Market Development and Trends

COVID-19 and Molecular POC
CDC Initial Response, Long-Term Situation
COVID-19's Unique Challenge
Barda Directs Funding to MPOC
Regulatory Developments
Consortia, Funding, Prizes
Deals
Advantages and Disadvantages of Molecular Point-Of-Care
Justification: The Sensitivity/Specificity Argument
New Systems and Menu Expansion
Mesa Biotech Strep an Approval
Combination Tests Changing Market: Sars-Cov-2, Flu A, Flu B, and RSV
STI Continues to be a Growth Area
Deals, Investment in MPOC Systems
Roche Acquires Lumiradx for Up to $350M
Thermo Acquires Mesa Biotech
EU Researchers Awarded €3M to Develop POC Molecular Tests
Scope Fluidics AST System Sees Investment
China as a POC Market
Common Tests and Analytes in POC Diagnostics
Component Technologies of Molecular Point-Of-Care Diagnostics
Microfluidics
qPCR
Microarrays
Isothermal Amplification
Test Automation
Primers and Probes
Detection
Next-Generation Sequencing
Molecular Diagnostics
Real-Time PCR (qPCR)
Isothermal Amplification Methods
Line Probe Assays
Next-Generation Sequencing
Applications and Potential Applications for Molecular Point-Of-Care
Major Testing Applications for Molecular POC Diagnostics
Influenza
Reclassification of RIDTs
Hospital-Acquired Infections (HAIs)
Strep A
Respiratory Syncytial Virus (RSV)
Emerging Applications
Zika
Other Respiratory Infections
Group B Streptococcus
Human Papillomavirus
Herpes Simplex Virus
Vaginitis
Tuberculosis
Malaria
Other Tropical and Neglected Diseases
Cancer
European Device Regulations

Chapter 3: Market Analysis

Molecular Point-Of-Care Market Analysis
"Near Patient Molecular" Market
Market Share Near Patient

Chapter 4: Company Profiles

Abbott Laboratories
Aidian
Akonni Biosystems
Binx Health
Biocartis
Biomerieux
Cepheid
Credo Diagnostics Biomedical Pte. Ltd.
Cue Health
Curetis
Diasorin
Genmark Diagnostics
Greiner Bio-One
Lucira Health
Meridian Bioscience
Mesa Biotech
Qiagen
Quantumdx Group
Quidelortho
Roche
Sekisui Diagnostics
T2 Biosystems

For more information about this report visit https://www.researchandmarkets.com/r/o5ztpv

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets